探索Helicobacter pylori,胃微生物群和胃癌之间的联系
Costantino Sgamato1, Alba Rocco1, Debora Compare1
1Gastroenterology Unit, Department of Clinical Medicine and Surgery, University Federico II of Naples, 80131 Naples, Italy.
Antibiotics (Basel, Switzerland)
|June 27, 2024
概括
杆菌感染和胃微生物群的改变是胃癌发展的关键因素. 这篇评论探讨了这些微生物变化如何驱动胃内膜的恶性转变.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 微生物学 微生物学
背景情况:
- 胃癌 (GC) 仍然是一个重大的全球健康挑战,导致高癌症相关死亡率.
- 了解GC的病原发生是改善患者治疗和预后的关键.
- 杆菌 (H. pylori) 和胃微生物群之间的相互作用越来越被认为对GC发展至关重要.
研究的目的:
- 审查当前关于H. pylori和非H. pylori胃微生物群在胃癌发生过程中的关系的文献.
- 要突出微生态失生症有助于胃粘膜的恶性转变的机制.
主要方法:
- 对研究H.pylori,胃微生物群和胃癌的文献综述.
- 对将微生物失调与胃癌发生联系的拟议机制的分析.
主要成果:
- 杆菌感染启动胃粘膜的炎症反应和分子变化.
- 非H. pylori的胃微生物群在调节GC疾病进展方面发挥着作用.
- 微生态失生症与胃粘膜的恶性转变有关.
结论:
- 杆菌和胃微生物群之间的复杂相互作用显著影响胃癌发生.
- 准微生物失生症是预防和治疗胃癌的潜在治疗策略.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
355
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
355
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
567
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
567
Peptic Ulcer Disease I: Introduction
162
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
162
Gastritis-II: Pathophysiology
312
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
312
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
374
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
374
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
109
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
109


